ClinConnect ClinConnect Logo
Search / Trial NCT05773482

Effects of Breathing and Attention Training (BAT) on Pain Modulation

Launched by UNIVERSITY OF FLORIDA · Mar 6, 2023

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how Breathing and Attention Training (BAT) can help manage pain in people with fibromyalgia, a condition that causes widespread pain and sensitivity. BAT is a mindfulness technique that combines focused breathing with paying attention to your thoughts and feelings. The researchers believe that this training could help improve the way people with fibromyalgia experience pain, making them feel less sensitive to it.

To be eligible for the trial, participants must be diagnosed with fibromyalgia and have experienced pain for more than six months. They are looking for adults aged 18 to 65 who are willing to stop taking certain pain medications during the study. Healthy individuals without chronic pain will also be included for comparison. Participants can expect to engage in breathing exercises and mindfulness practices to see if these techniques can help reduce their pain levels. The study is currently recruiting, so it’s a great opportunity for those looking for new ways to manage their fibromyalgia symptoms.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Individuals diagnosed with fibromyalgia will have pain of duration \> 6 months and meeting the 1990 Research Diagnostic Criteria for FM (ACR)
  • Healthy, pain-free age matched controls without chronic pain
  • Exclusion Criteria:
  • Personal or family history of photosensitive epilepsy
  • Prior history of cancer or diabetes
  • Patients must be willing to discontinue their analgesics, hypnotics, anxiolytics, or anti-depressants during the study period for at least 5 half-lives.

About University Of Florida

The University of Florida, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and exploring new therapeutic avenues, the university leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous research across a variety of medical fields. Committed to ethical standards and patient safety, the University of Florida fosters collaboration among researchers, healthcare professionals, and community stakeholders to translate scientific discoveries into impactful clinical applications.

Locations

Gainesville, Florida, United States

Patients applied

0 patients applied

Trial Officials

Roland Staud, MD

Principal Investigator

University of Florida

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials